Entire cycle of drug development and distribution
Eight products in portfolio to enhances women’s quality of life
Aicore Life Sciences welcomes partners to join its business

Registration obtained for Airing™ in Moldova

February 2022In January 2022 marketing authorization was received in Moldova for Airing™. Airing™ has been licensed from Mithra (Belgium) and is a generic version of...

Learn more »

Aicore Life Sciences receives exclusive licenses from Mithra for commercialization of Myring™ (Air…

25 October 2019 Liege, Belgium, 24 October 2019 – 7 :30 CEST – Mithra (Euronext Brussels: MITRA), a company dedicated to Women’s Health today announces that...

Learn more »

Bacterial vaginosis: further update on the development of Aicore Life Sciences’ new product

19 August 2019 New interim results confirm the findings of February this year Lactate Ring (an Intravaginal Drug-Delivery System with Sustained DL-Lactic Acid Release) is a vaginal...

Learn more »

Update on the development stages of Aicore Life Sciences’ new treatment for bacterial vaginosis

4 February 2019 Interim results of the clinical trial (“proof of concept”) for the vaginal ring containing lactic acid as an active ingredient are positive. The trial...

Learn more »

Aicore Life Sciences welcomes partners providing services or participating in the risks and benefits of the business. We have the advantage of embracing the whole process of drug development from early and pre-clinical phases, to promoting a product on the pharmacy’s shelf. This sets us apart from many other companies operating in the same field.

 frontpage cooperation